Logo
x

Search

Subscribe Now

Partner

Formycon with its Partner BIOEQ Plans to Initiate P-III MAGELLAN-AMD Trial for its FYB203 (biosimilar- aflibercept)

Formycon with its Partner BIOEQ Plans to Initiate P-III MAGELLAN-AMD Trial for its FYB203 (biosimilar- aflibercept)

  • August 24, 2020
Pfizer with its Partner BioNTech Receives the US FDA's Fast Track Designation for Two mRNA Based Therapies to Treat COVID-19

Pfizer with its Partner BioNTech Receives the US FDA's Fast Track Designation for Two mRNA Based Therapies to Treat COVID-19

  • July 13, 2020
Regeneron with its Partner NIAID Report the Initiation of P-III Trial to Evaluate REGN-COV2 for Treatment and Prevention of COVID-19

Regeneron with its Partner NIAID Report the Initiation of P-III Trial to Evaluate REGN-COV2 for Treatment and Prevention of COVID-...

  • July 6, 2020
Biocad with its Partner ICM Received the Registration Certificate for two of its Biosimilar in EU

Biocad with its Partner ICM Received the Registration Certificate for two of its Biosimilar in EU

  • March 30, 2020
Sorrento's Partner Mabpharm Files NDA to the NMPA for Infliximab Biosimilar in China

Sorrento's Partner Mabpharm Files NDA to the NMPA for Infliximab Biosimilar in China

  • January 7, 2020
AbbVie Signs a Partner and Option to Acquire Agreement with TeneoOne for its TNB-383B

AbbVie Signs a Partner and Option to Acquire Agreement with TeneoOne for its TNB-383B

  • February 13, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.